Plazza raises $15M Series A led by Accel, Elevation and Nexus to scale instant medicine delivery

Bengaluru-based quick-commerce pharmacy startup Plazza closed a $15M Series A, jumping from a $1.4M seed, as it reports 27X GMV growth and 40,000 SKUs. The raise comes as Flipkart Minutes, Zepto and Blinkit push deeper into 10-minute medicine delivery.

— FiledMon, 20 Jul, 2026, 10:19 IST·First seen Mon, 20 Jul, 2026, 10:18 IST·Source Entrackr

What happened

Quick commerce pharmacy startup Plazza raised $15M Series A led by Accel, Elevation and Nexus, as competition intensifies with Flipkart, Zepto and Blinkit

Key facts

  • $15 million
  • $1.4 million seed
  • 40,000 SKUs
  • 95% fill rate
  • 27X GMV growth
  • 30% larger repeat baskets

Why this matters

Plazza's rapid scale-up makes it both a potential acquisition target and a competitive threat, warranting close monitoring as quick-commerce giants deepen their pharmacy verticals.

What to watch

  • Zepto or Blinkit ring-fencing capital specifically for medicine delivery verticals
  • Any CDSCO/state drug-license compliance notice on quick-commerce pharmacy players
  • Plazza's dark-store count and city expansion pace over next 2 quarters
  • Founder/executive movement between Plazza and Zepto/Blinkit pharmacy teams
  • New entrant or PharmEasy/1mg pivot into instant delivery
  • Plazza accelerates dark-store/pharmacy license expansion into 2-3 new metros to defend market share before Series B
  • Hires Chief Pharmacist/Compliance Officer publicly to preempt regulatory risk narrative
  • Signs exclusive supply deals with pharma distributors or diagnostic chains to lock in SKU moat
  • Zepto/Blinkit announce dedicated 'pharmacy vertical' funding or spin-off to counter-position
  • Elevation/Accel signal follow-on reserve capital, hinting at fast Series B within 9-12 months

Also reported by